Gastrointestinal perforation in metastatic carcinoma: a complication of bevacizumab therapy.

Hdl Handle:
http://hdl.handle.net/10147/207583
Title:
Gastrointestinal perforation in metastatic carcinoma: a complication of bevacizumab therapy.
Authors:
Collins, D; Ridgway, P F; Winter, D C; Fennelly, D; Evoy, D
Affiliation:
Department of Surgery, St Vincent's University Hospital, Elm Park, Dublin 4,, Dublin, Ireland. daniellecollins@rcsi.ie
Citation:
Eur J Surg Oncol. 2009 Apr;35(4):444-6. Epub 2008 Apr 15.
Journal:
European journal of surgical oncology : the journal of the European Society of, Surgical Oncology and the British Association of Surgical Oncology
Issue Date:
1-Feb-2012
URI:
http://hdl.handle.net/10147/207583
DOI:
10.1016/j.ejso.2008.02.013
PubMed ID:
18417314
Language:
eng
MeSH:
Abdominal Pain/drug therapy/etiology; Aged; Angiogenesis Inhibitors/*adverse effects; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Antibodies, Monoclonal/*adverse effects; Antibodies, Monoclonal, Humanized; Carcinoma/complications/*drug therapy/*secondary; Confounding Factors (Epidemiology); Female; Humans; Intestinal Perforation/*chemically induced; Male; Middle Aged; Wound Healing/drug effects
ISSN:
1532-2157 (Electronic); 0748-7983 (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorCollins, Den_GB
dc.contributor.authorRidgway, P Fen_GB
dc.contributor.authorWinter, D Cen_GB
dc.contributor.authorFennelly, Den_GB
dc.contributor.authorEvoy, Den_GB
dc.date.accessioned2012-02-01T10:32:03Z-
dc.date.available2012-02-01T10:32:03Z-
dc.date.issued2012-02-01T10:32:03Z-
dc.identifier.citationEur J Surg Oncol. 2009 Apr;35(4):444-6. Epub 2008 Apr 15.en_GB
dc.identifier.issn1532-2157 (Electronic)en_GB
dc.identifier.issn0748-7983 (Linking)en_GB
dc.identifier.pmid18417314en_GB
dc.identifier.doi10.1016/j.ejso.2008.02.013en_GB
dc.identifier.urihttp://hdl.handle.net/10147/207583-
dc.language.isoengen_GB
dc.subject.meshAbdominal Pain/drug therapy/etiologyen_GB
dc.subject.meshAgeden_GB
dc.subject.meshAngiogenesis Inhibitors/*adverse effectsen_GB
dc.subject.meshAnti-Inflammatory Agents, Non-Steroidal/therapeutic useen_GB
dc.subject.meshAntibodies, Monoclonal/*adverse effectsen_GB
dc.subject.meshAntibodies, Monoclonal, Humanizeden_GB
dc.subject.meshCarcinoma/complications/*drug therapy/*secondaryen_GB
dc.subject.meshConfounding Factors (Epidemiology)en_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHumansen_GB
dc.subject.meshIntestinal Perforation/*chemically induceden_GB
dc.subject.meshMaleen_GB
dc.subject.meshMiddle Ageden_GB
dc.subject.meshWound Healing/drug effectsen_GB
dc.titleGastrointestinal perforation in metastatic carcinoma: a complication of bevacizumab therapy.en_GB
dc.contributor.departmentDepartment of Surgery, St Vincent's University Hospital, Elm Park, Dublin 4,, Dublin, Ireland. daniellecollins@rcsi.ieen_GB
dc.identifier.journalEuropean journal of surgical oncology : the journal of the European Society of, Surgical Oncology and the British Association of Surgical Oncologyen_GB
dc.description.provinceLeinster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.